Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
and marketed as Nimbex) is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs
which may result in the restoration of p53 signaling and
InChi: InChI=1S/C39H32ClF10N7O5S2/c1-36(2
Formula: C25H23BO4
Oclacitinib - CAS# 1208319-26-9 Catalog No.:M9848-2 and marketed as Nimbex) isOclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nM and did not inhibit a panel of 38 non JAK kinases (IC50 's > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1 dependent cytokines involved in allergy and
US$ 89.78
US$ 14.39
US$ 137.50
US$ 137.50
US$ 79.92
US$ 600.00
US$ 143.32
US$ 50.09
US$ 207.00